These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 11309348)
1. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Kim JH; Shin JH; Kim IH Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1174-80. PubMed ID: 15234053 [TBL] [Abstract][Full Text] [Related]
3. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380 [TBL] [Abstract][Full Text] [Related]
4. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice. Joung KE; Min KN; An JY; Kim DK; Kong G; Sheen YY Cancer Res; 2006 May; 66(10):5394-402. PubMed ID: 16707467 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Dalgard CL; Van Quill KR; O'Brien JM Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379 [TBL] [Abstract][Full Text] [Related]
6. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431 [TBL] [Abstract][Full Text] [Related]
7. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma. Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478 [TBL] [Abstract][Full Text] [Related]
10. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. de Ruijter AJ; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; Caron HN; van Kuilenburg AB Biochem Pharmacol; 2004 Oct; 68(7):1279-88. PubMed ID: 15345317 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. Choi YH Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY; Lai KP; Lui WC; Wan HT; Wong CK Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825 [TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Sekhavat A; Sun JM; Davie JR Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533 [TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. Kim DH; Lee J; Kim KN; Kim HJ; Jeung HC; Chung HC; Kwon HJ Biochem Biophys Res Commun; 2007 Apr; 356(1):233-8. PubMed ID: 17353008 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. Han SB; Lee JK Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980 [TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053 [TBL] [Abstract][Full Text] [Related]
18. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Frønsdal K; Saatcioglu F Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787 [TBL] [Abstract][Full Text] [Related]
20. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. Ishihara K; Hong J; Zee O; Ohuchi K Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]